Anavex Life Sciences Corp.

NasdaqGS:AVXL Stock Report

Mkt Cap: US$916.1m

Anavex Life Sciences Financial Health

How is Anavex Life Sciences's financial position?

Financial Health Score


Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: AVXL's short term assets ($152.7M) exceed its short term liabilities ($10.2M).

Long Term Liabilities: AVXL has no long term liabilities.

Debt to Equity History and Analysis

Debt Level: AVXL is debt free.

Reducing Debt: AVXL had no debt 5 years ago.

Balance Sheet

Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AVXL has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: AVXL has sufficient cash runway for 2.8 years if free cash flow continues to reduce at historical rates of 21.6% each year.

Discover healthy companies